Anirvan Ghosh, Chief Executive Officer at Unity Biotechnology, Inc. (UBX), sold 193,594 shares at $1.03 ($199K) on 2025-04-02, disclosed to the SEC on 2025-04-03.
Open-market sale of $199k UBX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.03 | 96,797 | $100K | 50.0% |
| 2 | $1.03 | 96,797 | $100K | 50.0% |
| Total | $1.03 avg | 193,594 | $199K | 100% |
| Filing → |
| UBX | SELL | 2024-08-06 | $924 | — | Filing → |
| UBX | SELL | 2024-06-26 | $2K | — | Filing → |
| UBX | SELL | 2024-05-03 | $935 | — | Filing → |